VISUfarma España Revenue and Competitors
Estimated Revenue & Valuation
- VISUfarma España's estimated annual revenue is currently $1.6M per year.
- VISUfarma España's estimated revenue per employee is $201,000
Employee Data
- VISUfarma España has 8 Employees.
- VISUfarma España grew their employee count by -20% last year.
VISUfarma España's People
| Name | Title | Email/Phone |
|---|
VISUfarma España Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $19.7M | 98 | 5% | N/A | N/A |
#2 | $19.7M | 98 | 42% | N/A | N/A |
#3 | $10.5M | 52 | -17% | N/A | N/A |
#4 | $32.4M | 161 | 11% | N/A | N/A |
#5 | $49M | 244 | 6% | N/A | N/A |
#6 | $7.2M | 36 | N/A | N/A | N/A |
#7 | $36.8M | 183 | 9% | N/A | N/A |
#8 | $44.8M | 223 | 13% | N/A | N/A |
#9 | $147.9M | 736 | 10% | N/A | N/A |
#10 | $29.3M | 146 | -5% | N/A | N/A |
What Is VISUfarma España?
VISUfarma es una empresa farmacéutica paneuropea especializada en oftalmología con una clara misión: traer a Europa los avances en salud ocular de todo el mundo. Nuestro compromiso es ofrecer productos de alta calidad y difundir en toda Europa las innovaciones y conocimientos en salud ocular de todo el mundo. Actualmente Visufarma posee la patente de Coenzima Q10 con indicación oftálmica, principal molécula de nuestros productos.
keywords:N/A
N/A
Total Funding
8
Number of Employees
$1.6M
Revenue (est)
-20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
VISUfarma España News
2022-04-17 - El mercado de tratamiento del síndrome del ojo seco espera ...
Ltd., VISUfarma, Akorn Operating Company LLC, Bausch & Lomb Incorporated, ... Alemania, Italia, Reino Unido, Francia, España, Países Bajos,...
Other Companies in Madrid
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.8M | 8 | -27% | N/A |
#2 | $0.6M | 8 | 0% | N/A |
#3 | $0.6M | 8 | -33% | N/A |
#4 | N/A | 8 | 0% | N/A |
#5 | $1.2M | 8 | -27% | N/A |